Open AccessBook
Plant Secondary Metabolites: Occurrence, Structure And Role In The Human Diet
Alan Crozier,Michael N. Clifford,Hiroshi Ashihara +2 more
- 06 Jul 2014
408
TL;DR: The authors suggest that the use of probiotics and prebiotics to modulate the gut flora composition in old age and the impact of dietary modulation of the gut microflora through dietary means should be considered.
read more
Abstract: Plant secondary metabolites have been a fertile area of chemical investigation for many years, driving the development of both analytical chemistry and of new synthetic reactions and methodologies. The subject is multi-disciplinary with chemists, biochemists and plant scientists all contributing to our current understanding. In recent years there has been an upsurge in interest from other disciplines, related to the realisation that secondary metabolites are dietary components that may have a considerable impact on human health, and to the development of gene technology that permits modulation of the contents of desirable and undesirable components. Plant Secondary Metabolites: Occurrence, Structure and Role in the Human Diet addresses this wider interest by covering the main groups of natural products from a chemical and biosynthetic perspective with illustrations of how genetic engineering can be applied to manipulate levels of secondary metabolites of economic value as well as those of potential importance in diet and health. These descriptive chapters are augmented by chapters showing where these products are found in the diet, how they are metabolised and reviewing the evidence for their beneficial bioactivity. © 2006 by Blackwell Publishing Ltd.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Stability of Essential Oils: A Review
TL;DR: Focusing on individual essential oils, the various paths of degradation upon exposure to extrinsic parameters are outlined and temperature, light, and oxygen availability are recognized to have a crucial impact on essential oil integrity.
1K
Significance of antioxidant potential of plants and its relevance to therapeutic applications.
TL;DR: The physiology and redox biology of both plants and humans are reviewed to improve the understanding of plant antioxidants as therapeutic entities and the applications and limitations of antioxidant activity measurement assays were highlighted to identify the precise path to be followed for future research in the area of plant antioxidant research.
Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.
TL;DR: This review assesses the current evidence for the efficacy of a range of readily available plant-based extracts and chemicals that may improve brain function and which have attracted sufficient research in this regard to reach a conclusion as to their potential effectiveness as nootropics.
709
Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
Ana Rodriguez-Mateos,David Vauzour,Christian G. Krueger,Dhanansayan Shanmuganayagam,Jess D. Reed,Luca Calani,Pedro Mena,Daniele Del Rio,Alan Crozier +8 more
TL;DR: Recent findings on the bioavailability and biological activity of (poly)phenols are summarized, focusing on the epidemiological and clinical evidence of beneficial effects of flavonoids and related compounds on urinary tract infections, cognitive function and age-related cognitive decline, cancer and cardiovascular disease.
551
A new perspective on the use of plant secondary metabolites to inhibit methanogenesis in the rumen
TL;DR: Although PSM may negatively affect nutrient utilization, there is evidence that methanogenesis could be suppressed without adversely affecting rumen fermentation, which could be exploited to mitigate methane emission in ruminants.
539
References
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Aram V. Chobanian,George L. Bakris,Henry R. Black,William C. Cushman,Lee A. Green,Joseph L. Izzo,Daniel W. Jones,Barry J. Materson,Suzanne Oparil,Jackson T. Wright,Edward J. Roccella +10 more
TL;DR: In those older than age 50, systolic blood pressure of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP, and hypertension will be controlled only if patients are motivated to stay on their treatment plan.
16.7K
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Salim Yusuf,Steven Hawken,Stephanie Ôunpuu,Tony Dans,Alvaro Avezum,Fernando Lanas,Matthew J. McQueen,Andrzej Budaj,Prem Pais,John Varigos,Liu Lisheng +10 more
TL;DR: Abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits, vegetables, and alcohol, and regular physical activity account for most of the risk of myocardial infarction worldwide in both sexes and at all ages in all regions.
12.3K
Global burden of hypertension: analysis of worldwide data
Patricia M. Kearney,Patricia M. Kearney,Megan Whelton,Kristi Reynolds,Paul Muntner,Paul K. Whelton,Jiang He +6 more
TL;DR: The overall prevalence and absolute burden of hypertension in 2000 and the global burden in 2025 were estimated to be about 1.56 billion (1.54-1.58 billion) and the number of adults with hypertension in 2025 was predicted to increase by about 60% respectively.
8.4K
The Chemistry behind Antioxidant Capacity Assays
TL;DR: This analysis suggests that the total phenols assay by FCR be used to quantify an antioxidant's reducing capacity and the ORAC assay to quantify peroxyl radical scavenging capacity, to comprehensively study different aspects of antioxidants.
6.3K
A critical review: vitamin b deficiency and nervous disease.
C. D. Aring,Tom Douglas Spies +1 more
TL;DR: The artificial synthesis of a number of the components of the vitamin B complex has made available pure crystalline material in large amounts for clinical research, and thus a milestone in the history of these affections has been passed.
5.3K